bipolar i disorder
Showing 51 - 75 of 104
Bipolar I Disorder, Manic Episode Trial in Worldwide (Brexpiprazole, Placebo)
Completed
- Bipolar I Disorder
- Manic Episode
- Brexpiprazole
- Placebo
-
Little Rock, Arkansas
- +47 more
Feb 3, 2020
Bipolar Disorder, Bipolar Depression, Bipolar I Disorder Trial in Brussels, Duffel (cTBS, Sham cTBS)
Unknown status
- Bipolar Disorder
- +6 more
- cTBS
- Sham cTBS
-
Brussels, Belgium
- +1 more
Apr 24, 2019
Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder Trial in Orangeburg (Betahistine, Placebo Oral Tablet)
Completed
- Schizophrenia
- +7 more
- Betahistine
- Placebo Oral Tablet
-
Orangeburg, New YorkNathan Kline Insitute for Psychiatric Research
Jan 20, 2019
Bipolar I Disorder Trial in Worldwide (Intramuscular (IM) Depot Aripiprazole, Intramuscular (IM) Depot Placebo)
Completed
- Bipolar I Disorder
- Intramuscular (IM) Depot Aripiprazole
- Intramuscular (IM) Depot Placebo
-
Birmingham, Alabama
- +76 more
Jul 24, 2018
Schizophrenia, MDD, Bipolar I Disorder Trial in United States (Aripiprazole + IEM (Ingestible Event Marker))
Completed
- Schizophrenia
- +2 more
- Aripiprazole + IEM (Ingestible Event Marker)
-
Granada Hills, California
- +3 more
Apr 27, 2018
Bipolar I Disorder Trial in United States (Quetiapine Fumarate)
Completed
- Bipolar I Disorder
- Quetiapine Fumarate
-
Garden Grove, California
- +6 more
Jan 19, 2018
Bipolar I Disorder Trial in Houston (Quetiapine Fumarate)
Completed
- Bipolar I Disorder
- Quetiapine Fumarate
-
Houston, TexasNovum Pharmaceutical Research Services
Jan 19, 2018
Emotional Intelligence in Schizophrenia and Bipolar-I- Disorder
Completed
- Schizophrenia
- Bipolar I Disorder
-
Innsbruck, AustriaMedical University Innsbruck
Sep 19, 2017
MDD, Bipolar I Disorder, Bipolar II Disorder Trial in Toronto (Ketamine, Midazolam, Treatment as usual (TAU))
Completed
- Major Depressive Disorder
- +4 more
- Ketamine
- +2 more
-
Toronto, Ontario, CanadaSunnybook Health Sciences Centre
Jul 25, 2017
Bipolar I Disorder Trial in United States (Inhaled Placebo, Inhaled loxapine 5 mg, Inhaled loxapine 10 mg)
Completed
- Bipolar I Disorder
- Inhaled Placebo
- +2 more
-
Escondido, California
- +5 more
Jun 28, 2017
Schizophreniform Disorder, Bipolar I Disorder, Bipolar II Disorder Trial in Toronto (Behavioural Intervention for the Prevention
Completed
- Schizophreniform Disorder
- +7 more
- Behavioural Intervention for the Prevention of Weight Gain
- TAU
-
Toronto, Ontario, CanadaCentre for Addiction and Mental Health
Jul 23, 2017
Schizophrenia, Schizo Affective Disorder, Bipolar I Disorder Trial (Financial incentive)
Unknown status
- Schizophrenia
- +2 more
- Financial incentive
- (no location specified)
Jun 18, 2017
Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder Trial in Chapel Hill (Latuda©)
Completed
- Schizophrenia
- +12 more
-
Chapel Hill, North CarolinaUniversity of North Carolina
May 18, 2017
Anxiety, Depression, Bipolar I Disorder Trial in United States (Ginger.io Smartphone Application)
Terminated
- Anxiety
- +3 more
- Ginger.io Smartphone Application
-
Meriden, Connecticut
- +3 more
Apr 24, 2017
Mania, Bipolar I Disorder Trial in Worldwide (Cariprazine, Placebo)
Bipolar I Disorder Trial in Vancouver (Lurasidone)
Completed
- Bipolar I Disorder
-
Vancouver, British Columbia, CanadaUniversity of British Columbia, Department of Psychiatry
Feb 1, 2017
Type 2 Diabetes, Schizophrenia, Schizoaffective Disorder Trial in Toronto (Lifestyle Intervention, Usual Care)
Completed
- Type 2 Diabetes Mellitus
- +7 more
- Lifestyle Intervention
- Usual Care
-
Toronto, Ontario, CanadaCentre for Addiction and Mental Health
Jun 15, 2016